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Quality of life in persons living with HIV–AIDS in
three healthcare institutions of Cali, Colombia
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SUMMARY
Antecedents: The Human Immunodeficiency Virus is currently considered a chronic disease; hence, quality of life is an
important goal for those suffering the disease or living with someone afflicted by the virus.
Objectives: We sought to measure the quality of life in individuals living with acquired immunodeficiency syndrome virus
and establish its relationship with socio-demographic and clinical variables.
Methods: This is a cross-sectional, descriptive study with a sample of 137 HIV-infected individuals attending three
healthcare institutions in the city of Cali, Colombia. Quality of life was measured via the HIV/AIDS-Targeted Quality of Life
(HAT-QoL) instrument. The descriptive analyses included mean and standard deviation calculations. To determine the
candidate variables, we used the student t test and the Pearson correlation. The response variable in the multiple linear
regression was the score for quality of life.
Results: Some 27% of the sample were women and 3% were transgender; the mean age of the sample was 35 + 10.2 years;
88% had some type of health insurance; 27% had been diagnosed with AIDS, and 64% were taking antiretroviral medications
at the time of the study. Quality of life was measured through a standard scale with scores from 0 to 100. Participants’ global
quality of life mean was 59 + 17.8. The quality-of-life dimensions with the highest scores were sexual function, satisfaction
with the healthcare provider, and satisfaction with life. The highest quality-of-life scores were obtained by participants who
received antiretroviral therapy, had health insurance, lower symptoms of depression, low frequency and intensity of
symptoms, and no prior reports of sexual abuse. Eight variables explained 53% of the variability of the global quality of life.
Conclusions: Those receiving antiretroviral therapy and who report fewer symptoms best perceived their quality of life.
Implications for practice: Healthcare providers, especially nursing professional face a challenge in caring to alleviate
symptoms and contribute to improving the quality of life of their patients.
Keywords: Quality of life; Symptoms,; HIV; AIDS; Health; Care; Nursing.
Calidad de vida en personas con VIH-SIDA en tres instituciones de salud de Cali, Colombia
RESUMEN
Antecedente: Hoy en día se considera el VIH como una enfermedad crónica; por tanto,la calidad de vida es una meta
importante de alcanzar en las personas que viven y conviven con el virus.
Objetivos: Medir la calidad de vida en personas que viven con el virus del sida y establecer la relación con variables socio-
demográficas y clínicas.
Métodos: Estudio transversal, descriptivo, con muestra no probabilística de 137 personas con VIH que asistieron a tres
instituciones de salud de Cali, Colombia. La calidad de vida se midió con el instrumento Hiv/Aids-Targeted Quality of Life
(HAT-QoL). El análisis descriptivo incluyó los cálculos de promedio y desviación estándar. Para determinar las variables
candidatas se utilizaron la prueba t de Student y la correlación de Pearson. La variable respuesta en la regresión lineal múltiple
fue el puntaje de calidad de vida.
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Resultados: De los encuestados27% eran mujeres y 3%
transgéneros; la edad promedio fue 35 + 10.2 años; 88% tenían
algún tipo de seguro de salud; 27% con diagnóstico de Sida
y 64% con tratamiento antirretroviral en el momento del
estudio. La calidad de vida se midió con una escala
estandarizada de 0 a 100; el promedio de calidad de vida global
fue de 59 + 17.8; las dimensiones de calidad de vida que mayor
puntaje obtuvieron fueron la función sexual, la satisfacción
con el proveedor de cuidados de salud y la satisfacción con
la vida. Los puntajes más altos en calidad de vida los obtuvie-
ron personas que recibieron tratamiento antirretroviral, con
acceso a algún seguro de salud, menor sintomatología depre-
siva, baja frecuencia e intensidad de síntomas y sin antece-
dentes de abuso sexual. Ocho variables explicaron 53% de la
variabilidad de la calidad de vida.
Conclusión: Las personas que reciben tratamiento
antirretroviral y que informan menos síntomas son quienes
mejor perciben su calidad de vida. Implicaciones para la
práctica. Los proveedores de salud especialmente los profe-
sionales de enfermería tienen un reto en el cuidado para aliviar
los síntomas y hacer un aporte a la calidad de vida de los
pacientes.
Palabras clave: Calidad de vida; Síntomas; VIH; Sida;
Salud; Cuidado; Enfermería.
Herein, we introduce the results obtained on quality
of life from the third study titled «Symptoms and self-
care in people with HIV-AIDS»1-3 conducted in different
nodes by the International Nursing and HIV-AIDS
Research Network, led by the University of California.
This article presents the results from the node in the city
of Cali, Colombia.
The concept of health and its relationship with quality
of life has been suggested by several authors from
different approaches. Health has been traditionally seen
as an aspect opposed to disease, even though the World
Health Organization (WHO) redefined it over five
decades ago as a state of complete wellbeing, still today
health and its promotion are not emphasized by the
programs of healthcare providers for individuals with
some diagnosis of chronic disease like that related to
Human Immunodeficiency Virus-Infected Individuals
(PLWHA); this has led healthcare providers and
researchers to make measurements of the health and
wellbeing of individuals in very limited manner4.
Quality of life is a goal of health systems and of public
health policies; quality of life is currently a measurement
that indicates the lack of or presence of wellbeing, it is
a measurement that is used as a positive indicator
regarding individuals’ relationship with health and it is
used to measure the effects or its relationship with
disease4.
Quality of life is a term implying happiness and
satisfaction with life and adequate functioning. It is a
very broad term and conceptually quite complex;
furthermore, it is a multidimensional concept. Health is
one of the dimensions of quality of life, but it is not the
nly one; other dimensions have to do with financial
aspects, interrelationships, sexuality, work, as well as
cultural and spiritual aspects5.
The path of the HIV disease is characterized by
episodes of acute exacerbation and long periods of
relative health6. If the HIV disease advances, the result
is diminished quality of life. Although quality of life is a
multidimensional construction that does not accomplish
universal agreement, some agreements have been
reached regarding its relationship with7. The WHO
defines it as the individual perception of the position
towards life within the context of culture and value
systems in which individuals live in relation to their goals,
expectations, standards, and concerns4.
Quality of life is a particularly important measurement
to determine the effects of the HIV-AIDS disease.
Bearing in mind that this is a chronic disease and that the
life expectancy of Human Immunodeficiency Virus-
Infected Individuals (PLWHA) is increasing because
of developments in treatments and the dramatic change
in mortality measurements, we do not expect deaths of
individuals infected by this virus if treatment is
appropiate8. In spite of this, it has been reported that
antiretroviral therapy (ARV) causes symptoms that
affect, to a greater or lesser degree, PLWHA and
impacts on their quality of life9.
Objectives
1. To measure the quality of life in a sample of individuals
living with the AIDS virus in the city of Cali, Colom-
bia.
2. To identify the relationship between global quality of
life and its specific dimensions to some clinical and
socio-demographic variables.
METHODOLOGY
Cross-section, observational, and descriptive study
conducted between 2005 and 2006, with a non random
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sample of 137 patients with HIV-AIDS attending
ambulatory services at three healthcare institutions in
Cali. The patients were approached on the day of their
medical or nursing consultation and those who accepted
voluntary participation and had the availability of time to
answer the survey were included. Among the inclusion
criteria defined were: subjects over 18 years of age,
with or without antiretroviral therapy, and with or without
AIDS diagnosis at the time of the study.
The instruments used in measuring the variables
included in the study have been broadly validated in
different research projects and are of free distribution
and use; these are: Demographic data questionnaire
(age, gender, social security), Depression Scale from
the Center for Epidemiological Studies [Escala de
Depresión del Centro de Estudios Epidemiológicos
(CES-D)], Revised Signs and Symptoms Checklist in
people with HIV (SSC-HIVrev), HIV/AIDS-Targeted
Quality of Life (HAT-QoL) instrument.
Depression Scale from the Center for Epidemio-
logical Studies (CES-D). Measures symptoms of
depression; it has 20 statements, responses range from
0 (never or rarely) to 3 (almost always or always). The
total sum may range from 0 to 60 and a score of 16 or
more indicates the need for a diagnostic evaluation for
major depression. An estimated Alpha coefficient of
0.90 was obtained in a sample of 727 AIDS patients9.
Revised Signs and Symptoms Checklist in people
with HIV (SSC-HIVrev). This is a 3-part checklist.
Part I consists of 45 points and 11 factors, with confidence
estimates ranging from 0.76 to 0.91; Part II consists of
19 symptoms related to HIV/AIDS, which are not
grouped into factors but which can be of interest from
the clinical perspective; and Part III has eight points
related to gynecological symptoms. These eight points
were subjected to principal components factor analysis
with varimax rotation (N = 118 HIV positive women),
which yielded a solution of a factor that explained 71.8%
of the variability; the confidence measurement of 0.9410
HIV/AIDS-Targeted Quality of Life (HAT-QoL).
This is a specific instrument to measure quality of life in
Human Immunodeficiency Virus-Infected Individuals
(PLWHA)11. It has nine dimensions: «General Function»
(which is a combination of the physical and social
functions); «satisfaction with life»; «concerns about
health»; «financial concerns»; «concerns about
medications»; «concerns about their HIV condition»;
«concerns about disclosing their diagnosis»; «confidence
in the healthcare provider»; «sexual function». The total
final evaluation was transformed into a linear scale from
0 to 100, where 0 is the worst possible score and 100 is
the best possible score.
The Project was approved by the Human Ethics
Review Institutional Committee at Universidad del Valle.
Prior to applying the data gathering instrument, the
informed consent form was read explaining the objectives
of the study and the conditions of free and voluntary
participation. All the participants signed the informed
consent form.
Data analysis. For the descriptive analysis of
quantitative variables like quality of life and frequency
of symptoms, the mean and standard deviation were
calculated and percentages were calculated in
categorical variables. The bivariate analysis to determi-
ne differences in quality-of-life scores included the
verification of the normality assumption with the
Kolmogorov-Smirnov (K-S) test, the Student t test, and
calculation of the Pearson correlation. The 95%
confidence interval (CI95%) was calculated for
measurement differences. The linear regression was
used to determine the factors related with quality-of-life
scores. The purpose with the construction of this model
was more explicative than predictive, which is why no
variable selection method was used. The global
adjustment of the model was verified with the one-way
ANOVA; the pertinence of each variable was verified
via the statistical t test; fitting of the model was verified
with the adjusted determination coefficient and the
assumptions of residues were verified through the
following manner:
1. Normality and zero means: with the K-S test, the Q-
Q plot, and the residue histogram
2. Homoscedasticity: via residue plot versus predicted
values.
3. No self-correlation: with the Durbin-Watson statistical
package.
4. Multicollinearity: with the Variance Inflation Factor
(VIF)
The results were analyzed via the SPSS version 13
statistical package.
RESULTS
The results were handled per instructions by the
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authors. The population studied consisted of 96 (71%)
men, 37 (27%) women, and 4 (3%) transgender; 88% of
the subjects reported having some type of health insurance,
most (57.3%) belonged to the subsidized healthcare
regime of the Health and Social Security System.
Twenty-seven percent had been diagnosed with AIDS
and 64% were receiving antiretroviral therapy at the
time of the study. Regarding age, the mean was 35.3 +
10.2 years with a range from 20-73 years, 9% were
above 50 years of age. The day of the interview, the
participants reported an average of 17+ 1 symptoms,
the data of the characteristics of the sample are published
in depth in another article by Valencia et al.1
Quality of life. The average global quality-of-life
score in the sample of patients was 59+17.8 points in a
standardized scale from 0-100. Table 1 shows the score
for each of the nine quality-of-life dimensions. Note that
the lowest scores in the dimensions correspond to
financial concerns (41.3) and to the difficulty of disclosing
their HIV condition (49.2). The dimensions revealing
the best scores are sexual function (81.4), satisfaction
with life (74.2), and satisfaction with attention received
from healthcare personnel (74.3).
The bivariate analysis per healthcare regime (type of
insurance) revealed that individuals in the contributive
regime had a better global score on the quality-of-life
scale compared to the global score of individuals with
subsidized regime (average: 66.21 vs. 53.8, respectively;
p=0.00). These statistically significant differences are
also observed in the scores for the following dimensions:
«general function», «concerns about health», «financial
concerns», and «concerns about their HIV condition»
(Table 2). Regarding sex, statistically significant
differences were only found in the dimension on concerns
about health, which is lowest for the female group (52.8
vs. 63.5; p=0.032).
Upon analyzing quality of life according to age,
statistically significant difference was only found in the
dimension for «confidence with the attention offered by
the healthcare provider»; this being the highest quality-
of-life score for those over 50 years of age (93 vs. 72.4;
p=0.0120).
No statistically significant differences were observed
between individuals with or without children under their
care. Regarding the relationship between quality of life
and treatment or not with antiretroviral medication
therapy (ARV), it was found that quality of life is
generally better for those taking the medications than
for those who were not taking them (66 vs. 46; p=0.00).
Analyzing the relationship between ARVT and the
different dimensions of the scale, significant differences
were noted in the dimensions dealing with «financial
concerns and concerns about disclosing their HIV+
condition» (47.6 vs. 30; p=0.001 and 70.1 vs. 49.7;
p=0.000, respectively). To explore the relationship
between symptoms and quality of life, we measured the
Table 1
Mean score of the dimensions in the scale for quality of life in
persons with HIV/AIDS in Cali, Colombia
Dimension  Mean (0-100)*   Standard deviation
QUALITY OF LIFE 58.8 17.8
General function 71.6 22.3
Satisfaction with life 74.2 21.0
Concerns about health 60.7 26.3
Financial concerns 41.3 31.5
Attitude towards ARV medication 72.4 23.6
Feelings about being HIV+ 62.9 33.6
Concern about disclosing HIV condition 49.2 28.6
Confidence with healthcare personnel 74.3 27.4
Sexual function 81.4 28.4
* Direct scale, higher scores indicate better quality of life
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relationship with the average frequency of symptoms,
the intensity of the symptoms, and the symptoms of
depression. The score for quality of life was lower
among those with symptoms of depression – both in the
global score (63.9 vs. 51.97; p=0.000) and in the
dimensions of general function (p=0.000), concerns
about health (p=0.02), concerns about their HIV
condition, concerns about ARV medications (p=0.008),
and sexual function (p: 0.005). The Pearson correlation
between quality of life and frequency of symptoms
revealed that as symptoms increase the quality of life is
impaired (r: -0.525 p<0.05) (Figure 1).
Multivariate analysis. To determine factors related
to quality of life and its nine dimensions, we used a
multiple linear regression for global quality of life and
nine models separated for each of the dimensions. Eight
of the nine variables included in the model for quality of
life explain 53% of the variability in quality-of-life
scores; however, it was found that only the frequency of
symptoms and the use of ARV therapy are significant
to explain quality of life (p<0.01). The negative coefficient
(-.340, t=-4.962, p=0.000), for the first variable, indicates
that the number of symptoms increase in an individual
with HIV, global quality of life diminishes; the positive
coefficient (.437, t=6.335, p=0.000), for the second
Table 2
Relationship between quality of life with socio-demographic and clinical variables
in Human Immunodeficiency Virus-Infected Individuals (PLWHA), Cali
Factor 1 Category Total           Mean ± SD 2                       CI95%3
Type of healthcare regime Subsidized 78 54.0 ± 17.6 6.3-18.2
Contributive 58 66.2 ± 15.8
ARV Treatment Yes 87 66.6 ± 15.7 16.1-26.8
No 49 46.0 ± 13.3
Symptoms of Depression Yes 7 42.3 ± 12.1 4.4-31.6
No 129 60.1 ± 17.7
Gender Female 37 57.2 ± 15.8 0.0-4.0
Male 95 60.2 ± 18.9
Emotional or physical abuse Yes 54 52.0 ± 16.2 6.2-18.3
No 82 64.0 ± 17.3
Sexual abuse Yes 22 46.3 ± 14.8 7.7-23.6
No 114 61.7 ± 17.3












































































































































Correlation (Pearson r) = -0.525
Significance (p<0.01)
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Figure 1.  Correlation between quality of life and
symptoms in PLWHA
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variable, indicates that individuals who received ARV
therapy have better quality of life than those who did not
receive it. The model fulfills all the statistical suppositions;
no multicollinearity problems were found, and the
variance was homoscedastic and the distribution of
residues was normal.
Table 3 shows the regression models for the
dimensions with the greatest number of independent
variables. It is noted that the amount of symptoms
(frequency of symptoms) negatively affects the following
dimensions: general function, satisfaction with life,
Table 3
Factors related to quality of life and two specific dimensions of quality of life
                            Multiple regression model for Quality of Life and Dimensions*
            Variables                  Standardized beta coefficient         R2 p
Global Quality of Life
    Constant
    Frequency of symptoms
    Depression
    Type of regime
    ARV treatment
    Abuse
    Physical abuse
    Sexual abuse
    Sex
Satisfaction with life
    Constant
    Frequency of symptoms
    Depression
    Abuse
    Physical abuse
    Sexual abuse
    Over 50 years of age
Worry about medications
    Constant
    Frequency of symptoms
    Depression
    ARV treatment
    Abuse
















































concerns about health, and concerns about medications.
For the dimension on concern about being HIV+, the
bivariate or multivariate analyses did not reveal varia-
bles to explain that dimension.
Increased frequency of symptoms, the presence of
depression, sexual abuse, and being over 50 years of age
negatively affect the dimension of «satisfaction with
life». These variables explain 31.8% of the variance for
this dimension. In the dimension on concern about ARV
medications, it is noted that taking them improves the
quality of life in said dimension by 26%, and along with
* The  models with the others dimensions were omitted because they did not provide optimum prediction
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the physical abuse and frequency of symptoms varia-
bles help to explain 45% of the variability in that
dimension.
Individuals over 50 years of age (p=0.021) who are
in the contributive healthcare regime (p=0.003), have
greater scores in the dimension of «confidence with the
healthcare provider»; both variables -along with the
constant- explain 21.1% of the global variability of that
dimension. In other dimensions, it is noted that quality of
life is affected by symptoms of depression and by being
or not being affiliated to healthcare insurance; the
dimension on «financial concerns» is negatively affected
in individuals with subsidized-type healthcare regime;
the sexual function dimension is most affected in
individuals suffering from depression (p=0.016).
DISCUSSION
The results in this study agree with reports from
other studies; diverse factors like the symptoms perceived
by PLWHA have been associated to lower quality-of-
life scores12; likewise, some social characteristics have
been associated with a low quality-of-life index13. In
contrast, factors like middle or high economic level in
terms of income and not having children under their care
have been associated to better quality of life14. In
general terms, it is observed that the global variability
explained by the variables in each of the dimensions is
quite high compared to results obtained by Phaladze K
et al.7
In this study, the patients with the highest quality-of-
life scores had better access to healthcare services.
Those affiliated to a contributive healthcare regime had
better-quality services; presenting fewer financial
concerns, fewer symptoms of depression, received
antiretroviral therapy, and experienced lower frequencies
and intensities of symptoms; they also evidenced fewer
antecedents of sexual or physical abuse. These findings
are similar to those reported by Phaladze et al.7 who
found a close correlation between intensity of symptoms
and low quality of life, at the expense of patients’
functional capacity impairment. Our results, like others,
show that high frequency and intensity of symptoms
have negative effects on quality of life15,16 and on
satisfaction for life; additionally, increased states of
depression impairs quality of life.
Several studies13,17,18 have identified an inversely
proportional relationship between quality of life and
poverty, as suggested by the results in this study. Hence,
the socioeconomic conditions determine greater vulne-
rability in acquiring the infection, as well as in living with
a better quality of life. This phenomenon denotes the
continuity of the chain of social factors characterizing
this disease, turning it into a vicious circle: lower income
is consequential of lack of work and, thus, less access to
healthcare services. This situation also diminishes
possibilities for access to antiretroviral therapy and to
integral healthcare services, which contributes to
worsening of psychological and physical conditions of
individuals affected by AIDS and their families. The
results confirm statements made by other authors in that
the quality of life of individuals with HIV/AIDS is a
complex constellation of disease, poverty, stigma,
discrimination, and lack of treatment.
This study did not reveal a statistically significant
association between quality of life and gender. A
significant relationship was only identified in one of the
dimensions in the quality-of-life scale, concerns about
health and gender, showing that women have a lower
quality of life with respect to concerns generated by
their health condition. Relationships with the adherence
variable are not presented in this article.
CONCLUSION
Frequency of signs and symptoms and taking ARV
medications were the variables most associated to
quality of life in inverse relationship for the first, i.e., a
greater number of signs and symptoms indicate lower
quality of life; and in direct association, for the latter,
meaning better quality of life among those receiving
medications. These aspects correlate with the natural
history of the disease, which has shown that the benefits
of antiretroviral therapy in terms of the prognosis are
greater than the adverse effects noted specifically at the
beginning of therapy.
These findings agree with those reported by other
authors like Wu12. Improving the immune system and
diminishing viremia translates to lesser symptoms,
lowered options of developing opportunistic infections,
and greater chances of reinsertion into the social environ-
ment and the labor market. These factors are undoubtedly
reflected in the different dimensions measuring quality
of life. Figure 2 presents the scheme of the variables
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related to global quality of life and with their dimensions
in individuals living with the AIDS virus.
Implications for practice and research .The HIV/
AIDS disease is a public health issue, given the dimensions
of its propagation. Given that it is a chronic disease, this
study suggests several challenges and questions to
address from different disciplines, especially from the
field of nursing: How to improve in society and in nursing
care the quality of life of individuals living with the AIDS
virus?
· Health professionals and society in general can
adopt positive attitudes and educate their patients to
live better with HIV/AIDS.
· Healthcare services must adequately and conti-
nuously provide medications to their users so they
can keep their illness under control.
· Nursing can teach and support strategies to reduce
functional limitations such as nutrition and exercise.
· Nursing can provide support and education for self-
care and family care that contribute to diminishing
the frequency and intensity of the symptoms.
· Maintaining a good quality of life requires healthcare
with a holistic and integral focus, given the different
dimensions that define it.
Limitations. This study was conducted on a non
random sample of patients among those attending health
ambulatory medical and nursing control services in three
healthcare institutions in the city of Cali. The results can
be extrapolated to patients with similar characteristics,
which is why we recommend further studies with
random samples of patients.
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Figure 2.  Graphic representation of the relationship among some variables and quality of life
(global and per dimension) in individuals living with the AIDS virus in
some healthcare institutions in Cali, Colombia
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